| BNFO 301 |
Items for each day generally indicate what is to be done before class |
Spring 2011
|
|
|
|
|||
| 2: Genome Sequencing
Notes - Overview of genome sequencing Notes - Where sequences come from Article: Myers et al. (2000) + Tour Questionnaire Please e-mail responses to any part of Problem Set 1 by end of Friday |
||||
| 7: Genome Sequencing
Article: Myers et al. (2000) + Tour (especially SQ14 of the tour) Questionnaire Lab: Sequence Assembly example Problem Set 2: Molec Biol Investigations (by request) Problem Set 3: Genome sequencing |
9: Intro to Molecular Biology
Notes: Gene regulation and phage Questionnaire Please e-mail responses to any part of Problem Set 2 by end of Friday |
|||
| 14: Intro to Molecular Biology Article: Madsen et al. (1999) + Tour Discussion: Problem Set 3 (Genome sequencing) Questionnaire Lab: Problem Set 3 (Genome sequencing) |
16: General problem session Questionnaire - What questions to discuss? Special Review Session: 10:00AM-? BNFO Computer Lab Special Review Session: 4:30-6:00PM BNFO Computer Lab Exam 1 distributed < 6:15 PM What to expect Ground rules Part I due Friday, Feb 16, 5:30 PM |
|||
| 21: Exam 1 due 8:30 AM Post-exam questionnaire Genome Analysis (no reading for today) Post-mortem: Exam 1 Lab: Intro to BioBIKE Notes: Introduction to mapping Notes: Elements of a loop Problem Set 4: Practice with loops and mapping |
23: Genome Analysis Notes: Search for FMRP in Drosophila Notes: Introduction to mapping Notes: Elements of a loop Post-mortem: Exam 1 (continued) Questionnaire Please e-mail responses to any part of Problem Set 4 by end of Friday |
* | ||
| 28: Genome Analysis Article - Hatfull et al (2008) review + tour (Part I and Part II) Questionnaire Lab: Intro to BioBIKE and Statistics Problem Set 5 - Blast and Dotplot OR Tour - Was Mendel Right? (Part I and Part II) Problem Set 6 - Statistics |
||||
|
* David Harper, Chief Scientific Officer and founder of BioControl will speak at 10:00 AM, Friday, February 25, Harris Hall Rm 2122, on phage therapy. You can read here about BioControl's approach and Sulakvelidze et al (2001) for a general account of phage therapy. | ||||